Resultados de la búsqueda 871-880 of 3463 for Anabolic

  1. Neurología - Ensayos clínicos

    We aim to determine whether cognitive impairment attributable to cerebral hemodynamic impairment in patients with high-grade asymptomatic carotid artery ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to assess the safety and tolerability of escalating intratumoral doses of mRNA-2752 in participants with relapsed/refractory solid ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

  4. Oncología (médica) - Ensayos clínicos

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  5. Oncología (médica) - Ensayos clínicos

    Global Cardio Oncology Registry ... Rochester, Minn. The purpose of this study is to provide a large database and platform for prospective sub-studies and ...

  6. Oncología (médica) - Ensayos clínicos

    This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with rituximab and to see how well this combination ...

  7. Oncología (médica) - Ensayos clínicos

    Patients with recurrent, platinum-sensitive high-grade serous ovarian cancer (HGSOC) including fallopian tube and primary peritoneal cancer expressing high ...

  8. Oncología (médica) - Ensayos clínicos

    This trial studies how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the detection of ...

  10. Oncología (médica) - Ensayos clínicos

    Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...